Register
Journal Updates
eMediNexus Coverage from: 
FDA panel recommends Plazomicin for cUTI but not BSI
eMediNexus,  06 May 2018
remove_red_eye 826 Views
#Infectious Diseases #Pathology and Lab Medicine #Urology

0 Read Comments                

The US Food and Drug Administrations (FDAs) Antimicrobial Drugs Advisory Committee has recommended plazomicin by 15 votes to one for complicated urinary tract infections (cUTIs) but not for bloodstream infections (BSIs) in adults with limited or no treatment options.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now